Francesca Guijarro

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Álex Bataller, Ana Garrido, Francesca Guijarro et al. · Blood Advances · 2021 · 56 citations · Full text

Medicine, Hematology, Oncology +13

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma

Aina Oliver‐Caldés, Raquel Jiménez, Marta Español‐Rego et al. · Journal for ImmunoTherapy of Cancer · 2021 · 46 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Acute myeloid leukemia with <i>NPM1</i> mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease

Álex Bataller, Guadalupe Oñate, Marina Díaz‐Beyá et al. · British Journal of Haematology · 2020 · 44 citations · Full text

Medicine, Oncology, Chemotherapy +13

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*

Sabine Käyser, Robert K. Hills, Ralitsa Langova et al. · British Journal of Haematology · 2021 · 31 citations · Full text

Life Sciences, Genetics, Hematology +13

Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells

Josep María Cornet-Masana, Antònia Banús‐Mulet, Josep Maria Casasa i Carbo et al. · EBioMedicine · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +16